BRIEF-Medexus Pharmaceuticals Q2 Adjusted EBITDA USD 5.079 Million
Nov 11 (Reuters) - Medexus Pharmaceuticals Q2 net income USD 813 thousand.
Related stories
US Dollar Edges Higher Against Canadian Dollar
The US dollar climbed slightly against Canada's currency.
M impact | FX | Nov 13, 2026, 06:38 PM UTC
Dollar Hits One-Year Highs as Fed Tightening Risks Rise, Convera Says
Convera says the dollar has reached one-year highs as risks of Fed tightening rise.
M impact | FX | Nov 13, 2026, 02:07 PM UTC
Dollar Set for Best Week in Two Months as Yen Nears 160
The dollar held near 19-month highs and was set for its biggest weekly rise in two months. U.S. yields rose as bets on a larger rate hike increased, while the yen hovered around 16
M impact | FX | Nov 13, 2026, 12:51 PM UTC
Chilean Peso Falls 0.58%, Weakens Past 1,000 per Dollar
The peso weakened past 1,000 per U.S. dollar for the first time since January 2025.
M impact | FX | Nov 13, 2026, 12:27 PM UTC
Dollar Hits 19-Month High as Fed Rate-Hike Bets Firm
The dollar rises to a 19-month high against a basket of currencies as markets increase bets on another Federal Reserve rate hike in December, including the possibility of a 50-basi
M impact | FX | Nov 13, 2026, 11:13 AM UTC
Dollar Could Rise Further if U.S. PPI Is Firm, ING Says
ING's Chris Turner says firm U.S. wholesale inflation and signals of further Fed rate rises could extend the dollar's rally. He expects October U.S. PPI to keep the hot-inflation n
M impact | FX | Nov 13, 2026, 09:01 AM UTC